𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis

✍ Scribed by Dr. Peter J. Whitehouse; Donald L. Price; Arthur W. Clark; Joseph T. Coyle; Mahlon R. DeLong


Publisher
John Wiley and Sons
Year
1981
Tongue
English
Weight
691 KB
Volume
10
Category
Article
ISSN
0364-5134

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Parkinson's disease: Neuron loss in the
✍ Imaharu Nakano; Dr Asao Hirano πŸ“‚ Article πŸ“… 1984 πŸ› John Wiley and Sons 🌐 English βš– 787 KB

A representative region of the nucleus basalis of Meynert was investigated in 11 patients with idiopathic Parkinson's disease and compared with the identical region in 13 age-matched control subjects. Simultaneously, the cerebral cortex and the nucleus basalis i n the patients with Parkinson's disea

Loss of nucleus basalis neurons containi
✍ Elliott J. Mufson; Shuang Y. Ma; Elizabeth J. Cochran; David A. Bennett; Laural πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 323 KB πŸ‘ 2 views

Recent studies indicate that there is a marked reduction in trkA-containing nucleus basalis neurons in end-stage Alzheimer's disease (AD). We used unbiased stereological counting procedures to determine whether these changes extend to individuals with mild cognitive impairment (MCI) without dementia

Galanin immunoreactivity is increased in
✍ Dr M. Flint Beal; Usha MacGarvey; Kenton J. Swartz πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 561 KB

## Abstract A depletion of large cholinergic neurons in the nucleus basalis of Meynert is a consistent finding in Alzheimer's disease (AD). The nucleus basalis of Meynert also contains interneurons and afferents that may modulate its functioning. In the present study we examined neurochemical marke

Down-regulation of trkA mRNA within nucl
✍ Yaping Chu; Elizabeth J. Cochran; David A. Bennett; Elliott J. Mufson; Jeffrey H πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 445 KB πŸ‘ 1 views

## Abstract Recent studies indicate that trkA expression is reduced in end‐stage Alzheimer's disease (AD). However, understanding the neuropathologic correlates of early cognitive decline, as well as the changes that underlie the transition from nondemented mild cognitive impairment (MCI) to AD, ar